FDA: Stop Using Counterfeit Ozempic Now

The U.S. Food and Drug Administration announced a recall of a specific cough drop product on April 22, 2026. Medical Group Care, LLC is recalling its MGC Health Menthol Cough Drops in the 30-count Honey Lemon bag. The recall follows an FDA inspection of the manufacturing plant in China on August 15, 2025. Agency investigators noted observations that could affect the final product’s quality, safety, or composition.

Specific Product Details for Disposal or Return

Consumers should check their medicine cabinets and first-aid kits for the exact product. The recalled item is labeled as MGC Health, Menthol- Cough Suppressant, Oral Anesthetic. It comes in a 30-count bag with a honey lemon flavor. The National Drug Code (NDC) is 83698-114-30, and the Universal Product Code (UPC) is 383173000047. The product was distributed by Medical Group Care, LLC of Naples, Florida. The recalling firm is Xiamen Kang Zhongyuan Biotechnology Co., Ltd.

Consumers who have this product should not use it. You should either dispose of it safely or return it to the place of purchase for a refund. Contact a healthcare provider if you have used this product and have health concerns. Medical Group Care can be reached for questions at its customer service line.

Unspecified Manufacturing Issues Create Unacceptable Risk

The FDA has not released the specific observations from its facility inspection. This lack of detail is standard in early recall notices while the investigation continues. The agency’s recommendation for a recall means its experts identified potential problems significant enough to warrant public action. These problems could involve contamination, incorrect ingredient strength, or failures in sterility controls. Any deviation from strict manufacturing standards introduces unknown variables into a product intended for therapeutic use.

For individuals managing tinnitus or hearing conditions, introducing an uncontrolled variable is unwise. Otologist Dr. Sharon Chen of the Hearing Health Institute notes that the auditory system can be sensitive. “Products of uncertain quality pose an avoidable risk,” Chen said. “An oral anesthetic could contain impurities or inconsistent doses that might cause unexpected reactions.”

Why Hearing Health Advocates Are Watching

This recall highlights a broader principle for patient safety. Over-the-counter remedies are often used for throat irritation or cough that might accompany ear infections or seem related to tinnitus. Using a product with potential quality issues does not support overall health management. It could complicate existing conditions or create new health problems that distract from core hearing health goals.

Product recalls based on facility inspections are proactive. The FDA acts on potential risks before widespread consumer illness reports. This system relies on regulatory oversight and swift company action. Consumers must check recall notices and act on them promptly.

Always consult with a pharmacist or physician before using any medicinal product, especially if you have underlying health conditions. Report any adverse reactions from this product to the FDA’s MedWatch program.

Source:
FDA Safety Alerts